Market Closed -
Euronext Paris
11:35:17 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
1.142
EUR
|
-4.99%
|
|
-8.49%
|
-38.24%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
922.4
|
237.7
|
168.2
|
295.6
|
178
|
109.8
|
-
|
-
|
Enterprise Value (EV)
1 |
774.5
|
73.75
|
98.88
|
98.35
|
48.63
|
-55.2
|
-115.9
|
-11.11
|
P/E ratio
|
-4.73
x
|
-1.76
x
|
-1.89
x
|
-2.69
x
|
-2.66
x
|
-1.66
x
|
-2.99
x
|
-4.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
70.4
x
|
25.2
x
|
32.6
x
|
65.3
x
|
12.4
x
|
17.2
x
|
22.1
x
|
5.24
x
|
EV / Revenue
|
59.1
x
|
7.83
x
|
19.1
x
|
21.7
x
|
3.38
x
|
-8.66
x
|
-23.3
x
|
-0.53
x
|
EV / EBITDA
|
-5.21
x
|
-0.71
x
|
-1.2
x
|
-1.25
x
|
-0.59
x
|
0.44
x
|
0.9
x
|
0.12
x
|
EV / FCF
|
-5.8
x
|
-0.52
x
|
-1.01
x
|
-1.85
x
|
-1.03
x
|
0.26
x
|
0.5
x
|
0.05
x
|
FCF Yield
|
-17.2%
|
-192%
|
-99.1%
|
-54.1%
|
-97.5%
|
386%
|
200%
|
2,086%
|
Price to Book
|
4.23
x
|
1.36
x
|
1.88
x
|
1.61
x
|
1.39
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
46,987
|
54,815
|
54,983
|
93,967
|
96,256
|
96,173
|
-
|
-
|
Reference price
2 |
19.63
|
4.336
|
3.059
|
3.146
|
1.849
|
1.142
|
1.142
|
1.142
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/3/22
|
3/2/23
|
3/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
13.1
|
9.424
|
5.165
|
4.526
|
14.39
|
6.373
|
4.976
|
20.98
|
EBITDA
1 |
-148.8
|
-104.4
|
-82.28
|
-78.71
|
-82.74
|
-124.4
|
-128.4
|
-95.97
|
EBIT
1 |
-151.7
|
-112.6
|
-89.75
|
-90.72
|
-69.94
|
-133.3
|
-138
|
-115.1
|
Operating Margin
|
-1,158.02%
|
-1,194.25%
|
-1,737.63%
|
-2,004.17%
|
-485.96%
|
-2,091.25%
|
-2,772.74%
|
-548.64%
|
Earnings before Tax (EBT)
1 |
-153
|
-133.2
|
-144.5
|
-90.43
|
-66.54
|
-130.4
|
-136.2
|
-114.2
|
Net income
1 |
-153.6
|
-133.2
|
-144.5
|
-90.53
|
-66.54
|
-125.4
|
-118
|
-97.7
|
Net margin
|
-1,172.52%
|
-1,413.39%
|
-2,797.21%
|
-2,000%
|
-462.4%
|
-1,967.85%
|
-2,372.35%
|
-465.74%
|
EPS
2 |
-4.150
|
-2.466
|
-1.620
|
-1.169
|
-0.6954
|
-0.6890
|
-0.3820
|
-0.2330
|
Free Cash Flow
1 |
-133.5
|
-141.5
|
-97.98
|
-53.2
|
-47.43
|
-213.1
|
-231.7
|
-231.7
|
FCF margin
|
-1,019.02%
|
-1,500.93%
|
-1,896.99%
|
-1,175.25%
|
-329.59%
|
-3,343.51%
|
-4,656.25%
|
-1,104.52%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/3/22
|
3/2/23
|
3/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
6.038
|
7.6
|
4.067
|
2.653
|
2.423
|
1.488
|
2.125
|
-1.271
|
1.999
|
2.087
|
2.272
|
8.121
|
1.299
|
1.688
|
1.688
|
1.688
|
1.244
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-72.37
|
-66.58
|
-44.72
|
-12.71
|
-15.96
|
-23.19
|
-18.46
|
-35.44
|
-19.18
|
-22.68
|
-17.23
|
-10.91
|
-26.9
|
-31.68
|
-35.49
|
-39.53
|
-35.84
|
Operating Margin
|
-1,198.63%
|
-876.05%
|
-1,099.59%
|
-479.13%
|
-658.72%
|
-1,558.08%
|
-868.85%
|
2,788.29%
|
-959.09%
|
-1,086.96%
|
-758.33%
|
-134.31%
|
-2,071.43%
|
-1,877.05%
|
-2,102.29%
|
-2,342.02%
|
-2,880.95%
|
Earnings before Tax (EBT)
1 |
-73.24
|
-86.54
|
-44.97
|
-68.35
|
-15.82
|
-22.43
|
-17.71
|
-36.73
|
-18.63
|
-21.96
|
-15.81
|
-10.24
|
-25.33
|
-31.22
|
-36.92
|
-43.92
|
-
|
Net income
1 |
-73.79
|
-86.5
|
-44.96
|
-68.35
|
-15.9
|
-22.43
|
-17.71
|
-36.75
|
-18.63
|
-21.96
|
-15.81
|
-10.24
|
-25.33
|
-29.43
|
-33.47
|
-38.15
|
-
|
Net margin
|
-1,222.09%
|
-1,138.16%
|
-1,105.58%
|
-2,576.02%
|
-656.17%
|
-1,506.8%
|
-833.51%
|
2,890.74%
|
-931.82%
|
-1,052.17%
|
-695.83%
|
-126.04%
|
-1,950%
|
-1,743.65%
|
-1,982.59%
|
-2,259.96%
|
-
|
EPS
2 |
-
|
-
|
-
|
-0.2347
|
-0.2855
|
-0.3407
|
-0.1844
|
-0.4244
|
-0.1999
|
-0.2359
|
-0.1609
|
-0.1006
|
-0.2598
|
-0.1860
|
-0.1400
|
-0.1400
|
-0.1400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
7/31/20
|
3/11/21
|
3/3/22
|
5/2/22
|
8/1/22
|
11/3/22
|
3/2/23
|
5/4/23
|
7/31/23
|
10/31/23
|
3/7/24
|
5/7/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
148
|
164
|
69.3
|
197
|
129
|
165
|
226
|
121
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-133
|
-141
|
-98
|
-53.2
|
-47.4
|
-213
|
-232
|
-232
|
ROE (net income / shareholders' equity)
|
-105%
|
-80%
|
-105%
|
-65.6%
|
-43.5%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
4.640
|
3.190
|
1.630
|
1.950
|
1.330
|
-
|
-
|
-
|
Cash Flow per Share
|
-3.470
|
-2.570
|
-1.780
|
-0.6800
|
-0.4900
|
-
|
-
|
-
|
Capex
1 |
4.97
|
2.3
|
0.28
|
0.09
|
0.62
|
42.6
|
49
|
56.3
|
Capex / Sales
|
37.96%
|
24.36%
|
5.49%
|
2.08%
|
4.3%
|
668%
|
983.82%
|
268.36%
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/3/22
|
3/2/23
|
3/7/24
|
-
|
-
|
-
|
Last Close Price
1.142
EUR Average target price
4.733
EUR Spread / Average Target +314.48% Consensus |
1st Jan change
|
Capi.
|
---|
| -38.24% | 119M | | +15.54% | 78.51B | | +12.05% | 9B | | +58.17% | 4.96B | | -14.94% | 4.84B | | -.--% | 3.72B | | +21.94% | 2.48B | | -26.63% | 2.19B | | +16.75% | 2.12B | | -37.97% | 1.94B |
Specialty & Advanced Pharmaceuticals
|